Is cortisol involved in upper-body obesity?

Area of Science:

• Endocrinology
• Metabolic Diseases
• Human Physiology

Background:

• Obesity is a significant health issue linked to hypertension, diabetes, and heart disease.
• Waist-to-hip ratio (W/H) is a key indicator of fat distribution, distinguishing between upper (android) and lower (gynoid) body types.
• Upper body obesity is associated with a higher prevalence of metabolic complications compared to lower body obesity.

Purpose of the Study:

• To investigate the hypothesis that upper body obesity represents a distinct subgroup of obese individuals.
• To explore the association between upper body fat distribution and mild cortisol excess.
• To examine the potential role of cortisol in the development and maintenance of this specific obesity phenotype.

Main Methods:

• Evaluation of clinical significance of fat cell distribution variations.
• Utilizing the waist-to-hip ratio (W/H) as an index for fat distribution assessment.
• Comparison of clinical findings in upper body obesity with those in hypercortisol states.

Main Results:

• Studies indicate a higher prevalence of diabetes and hypertension in individuals with upper body fat distribution (high W/H ratio).
• Clinical manifestations of upper body obesity resemble those observed in hypercortisol states.
• Some obese subjects exhibit hypersecretion of cortisol and increased cortisol production rates.

Conclusions:

• Upper body obesity may constitute a unique subgroup characterized by regional fat distribution.
• Mild cortisol excess is hypothesized to be associated with this specific type of obesity.
• Further research is needed to precisely measure cortisol economy in obese subjects due to measurement challenges and physiological variability.